SCHEMBL13145134

SCHEMBL13145134

C[C@@H]1C[C@@H](c2ncc(-c3ccc(-c4ccc(-c5cnc([C@@H]6CCN(C)N6C(=O)OC(C)(C)C)[nH]5)cc4)cc3)[nH]2)N[C@@H]1C

nearest known ligand 0.45

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SSTR3 P32745 4/20 0.45
HPGDS O60760 3/20 0.43
KCNH2 Q12809 4/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2C9 P11712 3/20 0.40
NR1I2 O75469 1/20 0.40
ABCB11 O95342 1/20 0.40
OPRK1 P41145 1/20 0.40
PRCP P42785 7/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 1/20 0.38
GPR119 Q8TDV5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10132326 1.00 SSTR3 (0.45) SSTR3HPGDSKCNH2CYP3A4CYP2C9
SCHEMBL825074 0.90 HPGDS (0.50) SSTR3HPGDSKCNH2CYP3A4CYP2C9
SCHEMBL825066 0.90 SSTR3 (0.46) SSTR3HPGDSKCNH2CYP3A4CYP2C9
SCHEMBL825078 0.84 HPGDS (0.47) SSTR3HPGDSKCNH2CYP3A4CYP2C9
SCHEMBL825176 0.83 HPGDS (0.46) SSTR3HPGDSKCNH2CYP3A4CYP2C9
SCHEMBL1316015 0.79 HPGDS (0.41) SSTR3HPGDSKCNH2CYP3A4CYP2C9
SCHEMBL1316017 0.79 HPGDS (0.41) SSTR3HPGDSKCNH2CYP3A4CYP2C9
SCHEMBL1316016 0.79 HPGDS (0.41) SSTR3HPGDSKCNH2CYP3A4CYP2C9
SCHEMBL853975 0.78 HPGDS (0.43) SSTR3HPGDSPRCP
SCHEMBL13145752 0.78 HPGDS (0.43) SSTR3HPGDSPRCP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010117977-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-10-14 WO disclosed